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Abstract
Introduction: L-arginine (L-arg) and vitamin C supplementation may decrease fat accumulation and have a favourable effect on car-
bohydrate metabolism. This is partly caused by matrix metalloproteinases (MMPs), which are involved in adipocyte development and 
remodelling. Our study evaluated the effects of L-arg and vitamin C supplementation on the content of visceral fat (VF%), activity of 
MMPs, and insulin resistance (IR) in rats fed a high-fat diet (HFD).
Material and methods: The experiment was performed using 48 Wistar rats divided into four groups: Group 1 was fed a standard diet, 
Group 2 a HFD, Group 3 a HFD supplemented with L-arg (A), and Group 4 a HFD supplemented with L-arg and vitamin C (AC). The 
animals were euthanized after six weeks. The concentrations of serum glucose, insulin, MMP-2, and MMP-9, as well as IR by Homeostatic 
Model Assessment (HOMA) and VF% were measured. 
Results: Statistically significant increases in VF%, MMP-2, MMP-9, insulin, and HOMA-IR levels were observed in the HFD group when 
compared to the control group. A smaller increase in VF%, insulin, and HOMA-IR was seen in Group 3 (A) and 4 (AC). L-arg supplemen-
tation protected against increases in MMP-2 and MMP-9 in Group 3 (A) and 4 (AC). 
Conclusions:
1. L-arginine could protect from an increase in visceral fat through a change in the activity of MMPs and amelioration of insulin sensitiv-
ity in rats fed a HFD. 
2. The addition of vitamin C did not improve the effects of L-arginine supplementation.  (Endokrynol Pol 2015; 66 (6): 526–532)
Key words: L-arginin; visceral fat; metaloproteinases; rats; high-fat diet
Streszczenie
Wstęp: Suplementacja L-argininy (L-arg) i witaminy C może obniżać gromadzenie tłuszczu trzewnego i korzystnie wpływać na meta-
bolizm węglowodanów. Jednym z potencjalnych mechanizmów jest działanie metaloproteinaz (MMP), które uczestniczą w rozwoju 
i remodelingu tkanki tłuszczowej. Badanie zaprojektowano w celu oceny ochronnego wpływu suplementacji L-arg i witaminy C na 
zawartość wisceralnej tkanki tłuszczowej, aktywność MMP oraz insulinooporność (IR) u szczurów żywionych dietą bogatotłuszczową. 
Materiał i metody: 48 szczurów rasy Wistar rats przydzielono do 4 grup: żywionych dietą standardową (kontrola), bogatotłuszczową 
(HFD), HFD i L-arg (A), HFD, L-arg i witaminą C (AC). Po 6 tygodniach zwierzęta usypiano. Oceniono względną masę tłuszczu trzewnego 
(VF%), a także oznaczano stężenia glukozy, insuliny, MMP-2 i MMP-9 w osoczu. IR określono przy użyciu HOMA.
Wyniki: W grupie HFD obserwowano największy wzrost VF%, wskaźnika HOMA-IR, stężeń insuliny, MMP-2 i MMP-9 w stosunku do 
grupy kontrolnej, istotnie mniejszy wzrost VF% i stężenia insuliny i HOMA-IR stwierdzono w grupach A i AC. W grupach żywionych 
dietą wysokotłuszczową z dodatkiem L-arg (A i AC) nie stwierdzono wzrostu stężeń MMP-2 i MMP-9. 
Wnioski:
1. Suplemetacja L-argininą może chronić szczury żywione dietą bogatotłuszczową przed gromadzeniem tłuszczu trzewnego poprzez 
wpływ na aktywność metaloproteinaz oraz poprawę insulinowrażliwości. 
2. Dodatek witaminy C nie poprawia efektu suplementacji L-argininy.  (Endokrynol Pol 2015; 66 (6): 526–532)
Słowa kluczowe: L-arginina; tłuszcz trzewny; metaloproteinazy; szczury; dieta wysokotłuszczowa
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models of obesity [5]. In subjects with type-2 diabetes, 
larger adipocytes were observed than in the control 
group, and despite their similar adiposity, adipocytes 
showed a higher expression of matricellular MMP-2 [6]. 
MMP-9 is secreted by various cells in response to growth 
factors and cytokines [7]. Plasma levels of MMP-2 and 
MMP-9 are increased in obese patients [8]. Galardin, 
an MMP inhibitor administered to mice fed a high-fat 
(HF) diet, has been found to markedly reduce subcu-
taneous and gonadal fat deposits [9]. Increased plasma 
levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 have 
been reported in type-2 diabetes and acute coronary 
syndrome [10]; the highest levels of these parameters 
have been observed in patients with both type-2 diabe-
tes and acute coronary syndrome, reflecting abnormal 
extracellular matrix metabolism in these diseases [11]. 
Patients with (untreated) mild hyperlipidaemia have 
also been found to have increased levels of MMP-2, 
MMP-9, TIMP-1, and TIMP-2 when compared to the 
control group [12]. 
Nitric oxide (NO) is an important biological agent 
with a number of roles, exerting its effects in neurons, 
the cardiovascular system, and immune modulation 
[13]. NO is synthesised from L-arginine (L-arg) through 
the use of NO synthase. It has been observed that L-arg 
may decrease the accumulation of fat and favourably 
affect carbohydrate and lipid metabolism [14, 15].
Vitamin C is an essential dietary nutrient taking part 
in the biosynthesis of collagen and is a cofactor in the 
biosynthesis of many important substances, such as 
cholesterol, catecholamines, amino acids, and certain 
peptide hormones. Vitamin C is a potent antioxidative 
agent, it influences mitochondrial function by decreas-
ing the generation of reactive oxygen species (ROS) 
through stimulation of the activity of superoxide dis-
mutase and glutathione peroxidase and alteration of the 
activity of the electron transport chain [16]. Vitamin C 
also has anti-inflammatory properties [17]. Some data 
indicate that, in rodents, dietary supplementation with 
vitamin C could prevent fat deposition induced by 
a HF diet.
Currently there is a lack of research assessing the 
potential influence of L-arg (with or without the sup-
plementation of vitamin C) on MMP activity in the 
presence of metabolic disorders caused by HF diets. 
Our study was designed to examine the influence of 
L-arg and vitamin C on the content of visceral fat, the 
serum concentration of MMPs, and insulin resistance 
in rats fed a high-fat diet. 
Material and methods
The protocol of the study was approved by the local bioeth-
ical commission in Poznań (approval no. 20/2011) and was 
Abbreviations
ANOVA — analysis of variance 
HFD — high-fat diet 
HOMA — homeostasis model assessment 
IR — insulin resistance 
IGF-1 — insulin-like growth factor 1 
IVGTT — intravenous glucose tolerance test 
L-arg — L-arginine 
L-NAME — L-NG-Nitroarginine Methyl Ester 
mRNA — messenger ribonucleic acid 
MMP — metalloproteinase 
NO — nitric oxide 
NOS — nitric oxide synthase 
OLEFT rats — Otsuka Long-Evans Tokushima Fatty rats 
VF% — percentage of visceral fat 
PI3kinase — phosphoinositide-3-kinase 
SD — standard diet 
SEM — standard error of measurement 
TIMP — tissue inhibitor metalloproteinase 
Introduction 
It has been suggested that impaired adipocyte differ-
entiation plays an important role in the pathogenesis 
of obesity [1], and may be influenced by several po-
tential factors, such as: proinflammatory cytokines, 
chemokines, hormones, and matricellular proteins.
Increased gene expression of paracrine regulators 
could be involved in adipocyte differentiation within 
the stromal vascular fraction of adipose tissue, and may 
play an important role in obesity.
Matrix metalloproteinases (MMPs) are a family of 
molecules associated with the breakdown of the com-
ponents of the extracellular matrix; therefore, MMPs 
are involved in the development and remodelling of 
adipose tissue. They are differentially expressed in 
adipose tissue; in the two genetic models of obesity (ob/ 
/ob and db/db mice) and in the diet-induced model of 
obesity. The mRNA levels for MMP-2, MMP-3, MMP-12, 
MMP-14, MMP-19, and tissue inhibitor metalloprotein-
ase-1 (TIMP-1) were strongly increased in adipocytes 
of obese animals, in comparison with lean tissue. In 
contrast, MMP-7 and TIMP-3 mRNAs are markedly 
decreased in obesity [2].
Gelatinases (MMP-2 and MMP-9) are produced by 
many different vascular cells, including; endothelial 
cells, podocytes, pericytes, fibroblasts, and macrophages 
[3]. MMP-2 (gelatinase A, type IV collagenase) is an 
endopeptidase that degrades the basement membrane 
of adipocytes. In obesity, it may be responsible for the 
hypertrophic development of adipocytes and the for-
mation of adipocyte clusters [4]. An elevated expression 
of MMP-2 has been found in adipose tissue in mouse 
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carried out in accordance with the Interdisciplinary Prin-
ciples and Guidelines for the Use of Animals in Research, 
Testing, and Education issued by the New York Academy 
of Sciences Ad Hoc Committee on Animal Research.
Laboratory animals
Male and female Wistar rats (six weeks old, weighing 
160 ± 12 g) were purchased from the Department of 
Toxicology at the Medical University of Poznań, Poland. 
All rats were housed individually in carbonate cages in 
a temperature and humidity-controlled room on a 12-hour 
light and 12-hour dark cycle, designed for the purpose 
of the study. The temperature inside the rat cages was 
21 ± 2°C, and the relative humidity was 60 ± 5%. 
Experimental design
The experiment was performed using 48 Wistar rats. 
After a five-day period of adaptation to the laboratory 
conditions, the rats were randomly divided into four 
equal groups (male-to-female ratio 1:1):
 — Group 1 (control, SD; n = 12): untreated rats, were 
allowed free access to a standard diet;
 — Group 2 (high-fat diet, F; n = 12): were fed a high-
fat diet;
 — Group 3 (arginine group, A; n = 12): were fed 
a high-fat diet supplemented with L-arginine at a dose 
of 20 g/kg diet;
 — Group 4 (arginine and vitamin C group, AC; 
n = 12): were fed a high-fat diet supplemented with 
L-arginine at a dose of 20 g/kg diet and vitamin C 
at 100 mg/kg diet.
The animals were fed a standard semisynthetic 
diet based on the AIN-93M diet [18] or a high-fat diet 
with modified amounts of fat and sodium chloride. 
The components of the diet were obtained partly from 
Sigma-Aldrich Sp. z o. o. and Merck Sp. z o. o. (vitamins, 
minerals and sodium chloride), Hortimex Plus Sp. z 
o.o. (casein and starch), and a local market (lard, sun-
flower oil, sucrose). The full composition of both diets is 
presented in Table I. All rats were provided ad libitum 
diet and distilled water for 42 days. Food intake was 
measured daily and weight changes were monitored 
weekly. The rats were under veterinary supervision 
during the whole course of the experiment.
Dose, form, and route of administration of L-arg 
and vitamin C
The diet was supplemented with either L-arg or L-arg 
combined with vitamin C for six weeks. L-arg was ad-
ministered at a dose of 20 g/kg diet (Curtis Healthcare, 
Warsaw, Poland) and vitamin C at a dose of 100 mg/kg 
diet (Biofarm, Poznań, Poland). In this type of experi-
mental study, these are considered to be low standard 
doses of L-arginine and vitamin C. The appropriate 
value of wheat starch was removed from the diets, 
20 g in the case of L-arginine supplementation and 100 
mg for the diet supplemented with vitamin C. 
Collection of material
At the end of the experiment (day 42), after 16 hours 
of fasting, the rats were weighed, anaesthetised by an 
intraperitoneal injection of thiopental (40 mg/kg body 
mass), and euthanised by cardiac puncture. The blood 
samples were collected in serum separation tubes, 
and subsequently used for biochemical studies. The 
coagulated blood was left to clot at room temperature 
for 30 minutes; then it was centrifuged for 15 minutes 
at 2500 r.p.m. at a temperature of 4°C; and finally the 
supernatant fluid was separated. The serum samples 
used for analysis were stored at –70°C. Visceral perirenal 
fat was dissected, weighed, and frozen rapidly at –70°C.
Examined parameters
In all animals, weight gain and the absolute and relative 
weights of visceral fat were determined. The relative 
weight of visceral fat was defined as the percentage of 
the body weight.
Table I. Ingredient and nutrient composition of the diets 
(grams per kilogram diet)
Tabela I. Składniki odżywcze i skład diety (gramy na 
kilogram diety)
Ingredient Standard diet High-fat diet
Casein 140 140
Wheat starch 625 430
Sucrose 100 100
Potato starch 50 50
Vitamin mixture* 10 10
Mineral mixture** 35 35
Sunflower oil 40 40
Lard – 160
Sodium chloride – 35
Total energy (kcal/100g diet) 420 515
Total protein (% of energy) 18 18
Total fat (% of energy) 9 39
*composition of vitamin mixture (g/kg mix): nicotinic acid (3), Ca pantothenate 
(1.6), pyridoxine (0.7), thiamine (0.6), riboflavin (0.6), folic acid (0.2), biotin 
(0.02), vitamin B12 (0.003); vitamin E (500IU/g), vitamin A (500,000 IU/g), 
vitamin D3 (400,000 IU/g), vitamin K1 (0.08), choline bitartrate (200), powdered 
sucrose (777.15); **composition of mineral mixture (g/kg mix): calcium 
carbonate (357), potassium phosphate monobasic (250), potassium citrate 
(28), sodium chloride (74), potassium sulphate (46.6), magnesium oxide (24), 
ferric citrate (6.06),zinc carbonate (1.65), sodium meta-silicate 9H20 (1.45), 
manganese carbonate (0.64), cupric carbonate (0.30), chromium chloride 6H20 
(0.147), boric acid (0.0816), sodium fluoride (0.0635), nickel chloride 6H20 
(0.0578), lithium sulfate H20 (0.0263), sodium selenate anhydrous (0.0103), 
potassium iodate (0.010), ammonium paramolybdate 4H20 (0.0795), ammonium 
vanadate (0.066), powdered sucrose (209.758)
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Laboratory measurements
Fasting serum glucose concentration was analysed 
by an enzymatic method involving hexokinase and 
glucose-6-phosphate dehydrogenase (Siemens Health-
care Diagnostics, Erlangen, Germany).
The plasma concentration of insulin was determined 
by an enzyme-linked immunoassay, in strict accord-
ance with the manufacturer’s instructions (Demeditec 
Diagnostic GmbH, Kiel-Wellsee, Germany).
Insulin resistance was estimated by Homeostasis 
Model Assessment (HOMA), according to the formula: 
Insulin resistance index = fasting insulin (μg/L) × fast-
ing glucose (mg/dL)/405.
Serum MMP-2 and MMP-9 protein levels were deter-
mined using commercially available quantitative sand-
wich ELISA kits obtained from EIAab (Wuhan, China).
Statistical analysis 
Results are shown as mean ± SEM. Continuous 
variables were assessed for normal distribution with 
the use of the Shapiro-Wilk test. Differences between 
means were analysed by ANOVA, followed by Tukey’s 
post-hoc test. A P value of less than 0.05 was regarded as 
statistically significant. All calculations and demograph-
ics were performed with Statistica software (version 6.0 
for Windows).
Results
The average dietary intake, initial body weight, and 
weight gain were comparable in all groups (Table II). 
The relative mass of visceral fat (as a percentage of 
body mass) was significantly higher in rats fed a high-
fat diet, as compared to the control group. Rats fed 
a HF diet supplemented with L-arg or a combination 
of L-arg and vitamin C showed smaller increases in 
relative visceral fat. 
The results presented in Table III demonstrate 
a statistically significant increase (P < 0.05) in serum 
insulin and HOMA-IR levels, as well as in MMP-2 and 
MMP-9, in rats fed a HF diet. L-arg supplementation 
(alone or combined with vitamin C) protected against 
increases in MMP-2 and MMP-9, and partially protected 
against increases in the concentration of insulin and 
HOMA-IR levels. 
Discussion
A decreased accumulation of visceral fat was observed 
after L-arg supplementation, a new finding discovered 
during our study, which could be related to diminished 
MMP-2 and MMP-9 serum concentrations. Further-
more, our study confirms the beneficial influence of 
L-arg on insulin resistance. 
Our study demonstrates that the relative mass of 
the visceral fat (as a percentage of body mass) was 
significantly higher in rats fed a high-fat diet than in 
the rats from the control group. Both L-arg as well as 
the combination of L-arg with vitamin C diminished 
the relative mass of visceral fat comparably. Dietary 
supplementation with L-arg resulted in white-fat mass 
reduction in Zucker diabetic rats and in diet-induced 
obese rats; this fact has been confirmed by several 
studies [14, 15]. In Zucker diabetic rats, L-arg supple-
mentation reduced the epididymal and abdominal fat 
deposits by 28% and 46%, respectively. The weight of 
other organs remained unchanged. Supplementation 
with citrulline (a precursor of L-arg) also decreased 
the amount of fat [19]. The beneficial influence of 
L-arg supplementation on fat accumulation may 
also be associated with the role of nitric oxide (NO) 
in the regulation of fatty acid metabolism, glucose, 
and amino acids in all mammals, as well as in rats. 
Physiological concentrations of NO increase fatty acid 
Table II. Diet intake, initial body mass, and effects of dietary L-arginine with and without vitamin C supplementation on 
weight gain and visceral fat tissue
Tabela II. Wpływ suplementacji L-argininą i witaminą C na przyrost masy ciała i zawartość tkanki tłuszczowej trzewnej 
u szczurów, żywionych dietą bogatotłuszczową
Groups Parameters
Number of rats Diet intake  
[g/day]
Initial body  
mass [g]
Weight gain [g] Visceral fat/ 
/percentage of body 
mass (%)
Group 1 Control 12 18.9 ± 1.2 160.1 ± 14.2 115.7 ± 12.0 0.95a
Group 2 High fat diet 12 18.3 ± 1.0 159.5 ± 12.8 116.6 ± 13.2 1.23b
Group 3 L-arginine 12 18.4 ± 1.1 162.4 ± 12.5 111.5 ± 15.1 1.10ab
Group 4 L-arginine and 
vitamin C
12 18.4 ± 1.3 161.3 ± 13.1 105.6 ± 18.3 1.07ab
Values are means ± SEM for twelve rats, a, bsignificant differences between all groups (Anova test, p<0.05)
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oxidation in skeletal muscle, liver, and adipose tissue, 
while decreasing the synthesis of lipids in liver and 
adipose tissue. A possible explanation of the molecular 
relationship between NO and the amount of fat is the 
variable regulation of gene expression, affecting oxida-
tion, fat accumulation, and adipocyte differentiation 
[20]. Therefore, dietary L-arg supplementation reduces 
the size, although not the number, of adipocytes in 
obese rats [14, 15].
An important finding of our study is that the ben-
eficial effect of L-arg on visceral fat could be explained 
by a decrease of MMPs activity. In the group of rats fed 
a HF diet, a significant increase in visceral fat content 
was associated with elevated levels of MMP-2 and 
MMP-9, while supplementation of L-arg protected 
the rats fed a HF diet from increases in visceral fat 
and MMP concentration. It is possible that inhibition 
of MMPs activity, induced by L-arg, protected the 
HF-diet-fed rats from an increase in visceral fat. This 
potential beneficial effect of MMPs on adipose tissue 
was shown in earlier studies. In mice, after 15 weeks 
of a high-fat diet, the body weight gain in Ro 28-2653 
(a synthetic MMP-inhibitor treated group) was found to 
be lower, and the amounts of the isolated subcutaneous 
or gonadal fat deposits were diminished by 10–15%. 
Moreover, the number of adipocytes in adipose tis-
sue was higher (at 10–17%), but their diameter was 
smaller (by about 10%) [21]. Another MMP inhibitor 
(tolylsam), administrated to obese wild-type mice fed 
a HF diet, reduced total, subcutaneous, and gonadal 
adipose tissue [22]. De novo development of fat in mice 
injected with preadipocytes and kept on a HF diet was 
significantly impaired upon treatment with tolylsam; 
which was also responsible for the preservation of 
collagen and the reduction of blood-vessel size in adi-
pose tissue [23]. A possible explanation for this is that 
MMPs degrade the basement membrane of adipocytes, 
and are responsible for hypertrophic development of 
adipocytes and the formation of adipocyte clusters. 
Another explanation of the beneficial influence of 
L-arg on the visceral fat content in rats is its role in the 
regulation of carbohydrate metabolism and insulin 
sensitivity. We demonstrated a significant increase in 
serum insulin and HOMA-IR levels in rats fed a HF 
diet. L-arg alone and in combination with vitamin C 
partially decreased the insulin concentration and the 
HOMA-IR level when compared to the rats fed a HF 
diet. The results of a study by Alam et al. showed that 
L-arg supplementation in Wistar rats improved glucose 
tolerance while decreasing blood pressure, abdominal 
fat deposits, and oxidative stress [24]. On the other 
hand, NO synthesis inhibitors, such as NG-nitro-L-
arginine methyl ester (L-NAME), decrease insulin 
sensitivity and lipid metabolism, while the addition 
of L-arg reverses this effect. Moreover, a significant 
decrease in insulin sensitivity and plasma levels of 
postprandial triglyceride was detected by chronic 
treatment of L-NAME in diabetic rats [15]. It has been 
shown that short-term L-arginine supplementation 
in rats with ischemia-reperfusion syndrome causes 
a decrease in the insulin binding capacity of insulin 
receptors in skeletal muscle, and an increase in insulin 
level [25]. Newer studies show a pathophysiological role 
of NO in obesity-related insulin resistance; however, the 
results have been controversial. After 12 weeks of either 
a standard diet (SD) or a HF diet, alone or combined 
with L-NAME (100 mg/kg/d), it was found that L-NAME 
treatment significantly attenuated body-weight gain in 
both groups of mice without affecting calorie intake. 
Chronic NOS blockade by L-NAME in mice ameliorated 
HF diet induced adiposity and glucose intolerance; 
it also reduced adipose inflammation and improved 
insulin signalling in skeletal muscle [26]. 
The favourable effect of L-arg on insulin resistance 
could be explained partly by its positive influence on 
MMPs. MMP concentrations are elevated in hyperinsu-
linaemia and insulin resistance. Boden et al. observed 
the influence of elevated levels of insulin and FFA on 
Table III. Effects of dietary L-arginine with and without vitamin C supplementation on serum insulin concentration, resistance 
index (HOMA-IR), and MMP-2 and MMP-9 serum concentration in high-fat-diet rats
Tabela III. Wpływ suplementacji L-argininą i witaminą C na wskaźnik insulinooporności HOMA-IR, stężenia insuliny, 
MMP-2 i MMP-9 u szczurów, żywionych dietą bogatotłuszczową
Groups Parameters
Insulin [μg/L] HOMA-IR MMP-2 [ng/mL] MMP-9 [ng/mL]
Group 1 Control 0.31 ± 0.05a 0.08 ± 0.01a 1.64 ± 0.72a 4.55 ± 1.87a
Group 2 High fat diet 0.62 ± 0.07c 0.16 ± 0.03c 2.42 ± 0.90b 7.00 ± 2.15b
Group 3 L-arginine 0.46 ± 0.08b 0.11 ± 0.02b 1.55 ± 1.00a 4.85 ± 2.33a
Group 4 L-arginine and vitamin C 0.41 ± 0.05b 0.10 ± 0.01b 1.53 ± 0.82a 5.13 ± 1.69a
Values are means ± SEM for twelve rats, HOMA-IR-insulin resistance index, MMP-2 — metalloproteinase 2; MMP-9 — metalloproteinase 9; a, b, csignificant differences 
between all groups (Anova test, p < 0.005)
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MMPs and TIMP in the aortic tissue of male rats during 
euglycaemic-hyperinsulinaemic clamping. Hyperin-
sulinaemia led to increases in MMP-2 (approximately 
six-fold), MMP-9 (approximately 13-fold), but did 
not affect tissue inhibitors of MMPs [27]. Monti et al. 
demonstrated that sucrose-induced insulin resistance 
increased the expression of cardiac MMP-2 by a factor 
of 2.4, and of MMP-9 by a factor of 10.5, compared to 
Sprague-Dawley rats fed a standard diet. The explana-
tion that was discussed focused on insulin or insulin 
growth factor-1 (IGF-1) signalling PI3 kinase activation 
and the subsequent stimulation of MMPs [28].
Surprisingly, when L-arg supplementation was 
combined with vitamin C, we did not observe any ef-
fect on the levels of MMPs, the amount of visceral fat, 
insulin concentration, or HOMA when compared to 
L-arg supplementation alone. The effect of vitamin C 
has been consistently demonstrated in several studies; 
dietary supplementation with ascorbic acid reduces 
body weight and the amounts of retroperitoneal and 
subcutaneous fat deposits in cafeteria diet-induced 
obese rats, but our study did not confirm this finding 
[29]. The synergic action of dietary supplementation 
with phytosterol and ascorbic acid has been shown to 
reduce body mass accumulation and alter food tran-
sit time in a diet-induced-obesity mouse model [30]. 
Other studies also confirmed the advantageous effect 
of vitamin C on MMP. In pigs fed a high-cholesterol diet 
[31] the supplementation of vitamins C and E mark-
edly prevents lipid peroxidation, increases neointimal 
collagen content, and reduces hypercholesterolaemia-
induced changes in vascular MMP-1. The fibroblasts of 
aged human skin cultured in fragments, manifest raised 
intracellular oxidant levels; conversely, treatment with 
antioxidant MitoQ (10) significantly reduces MMP-1 
expression [32]. The underlying mechanisms that have 
been discussed include: upregulation of the expression 
of genes involved in cell proliferation, regulation of tran-
scription, as well as downregulation of genes involved 
in lipid metabolism, cell adhesion, and differentiation. 
A possible explanation for the lack of an effect of vitamin 
C combined with L-arg on MMP levels and insulin con-
centration, found in our study, is that the accumulation 
of vitamin C oxidation products may predispose tissues 
toward destabilisation or damage. This occurs partly 
through increased advanced glycation, especially under 
disadvantageous conditions such as diabetes, end-stage 
renal disease, or overalimentation [33].
Clinical relevance
In this study, we showed that L-arg supplementation, 
whether alone or in combination with vitamin C, 
protects rats fed a HF diet against increases in MMP-2, 
MMP-9, and visceral fat accumulation. Additionally, 
we confirmed the favourable effect of L-arg on insulin 
resistance. Although neither the decrease in serum 
concentrations of MMPs nor the augmentation of insu-
lin sensitivity completely explains the beneficial effect 
of L-arg and vitamin C on visceral fat accumulation. 
Identification of contributing factors may help in the 
prevention of obesity and its consequences, such as 
atherosclerosis or inflammation. 
Limitations
The activation of MMPs in different organs and tissues is 
regulated by NO through many potential mechanisms 
[34–39]. This relationship is described as being either 
organ-specific or tissue-specific [40–42]. We did not 
evaluate the levels of MMPs in adipose tissue; there-
fore, we could not explain how a change in fat mass, 
with a subsequent alteration in local environment, 
influences circulating blood levels of these proteins. 
Another limitation of this study was the absence of 
a group fed with a HF diet supplemented with vitamin 
C alone. Higher doses of L-arg and vitamin C, as well 
as a longer treatment period, could also influence the 
results more significantly. As our study is experimental, 
future studies that aim to verify its results should be 
performed in humans.
Conclusions
1. L-arginine protects rats fed a high-fat diet from an 
increase of visceral fat, possibly through a change 
in MMP-2 and MMP-9 activity and amelioration of 
insulin sensitivity. 
2. The addition of vitamin C did not improve the ben-
eficial effects of L-arginine supplementation. 
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